Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.
Liver Center, University of Kansas Medical Center, Kansas City, KS.
Hepatology. 2018 Mar;67(3):1109-1126. doi: 10.1002/hep.29587. Epub 2018 Jan 24.
Alcohol is a well-established risk factor for hepatocellular carcinoma (HCC), but the mechanisms by which it promotes liver cancer are not well understood. Several studies have shown that cellular protein arginine methylation is inhibited by alcohol. Arginine methylation is controlled by the reciprocal activity of protein arginine methyltransferases, primarily protein arginine methyl transferase 1 (PRMT1), and a demethylase Jumonji C domain-containing protein 6 (JMJD6). The aim of this study was to explore the role of arginine methylation changes in alcohol pathogenesis. We found that PRMT1 activity is inhibited in livers of mice fed with alcohol compared to pair-fed mice. Using hepatocyte-specific PRMT1 knockout mice, we identified that loss of PRMT1 results in enhanced hepatocyte proliferation and a 33% increase in liver size. This increased hepatocyte proliferation was associated with reduced expression of hepatocyte nuclear factor 4 alpha (Hnf4α), an important regulator of liver tumorigenesis. We found that PRMT1 regulates Hnf4α expression directly through arginine methylation at the (Hnf4α) promoter. In the absence of PRMT1, JMJD6 can demethylate the Hnf4α promoter and suppress its expression. We were able to restore Hnf4α expression and abolish the increase in hepatocyte proliferation by knockdown of JMJD6 in PRMT1 knockout mice. Knockdown of JMJD6 in alcohol-fed mice similarly increased Hnf4α expression. We then examined whether loss of arginine methylation might play a role in alcohol-associated liver cancers. We examined 25 human HCC specimens and found a strong correlation (R = 0.8; P < 0.01) between arginine methylation levels and Hnf4α expression in these specimens, suggesting that the above mechanism is relevant in patients.
Taken together, these data suggest that PRMT1 inhibition, such as induced by alcohol, may result in epigenetic changes leading to loss of Hnf4α. This effect may contribute to alcohol's ability to promote liver tumors. (Hepatology 2018;67:1109-1126).
酒精是肝细胞癌(HCC)的一个既定风险因素,但它促进肝癌的机制尚不清楚。几项研究表明,细胞蛋白精氨酸甲基化受酒精抑制。精氨酸甲基化受蛋白精氨酸甲基转移酶(主要是蛋白精氨酸甲基转移酶 1(PRMT1))和一种去甲基酶 jumonji C 结构域蛋白 6(JMJD6)的活性调节。本研究旨在探讨精氨酸甲基化变化在酒精发病机制中的作用。我们发现,与配对喂养的小鼠相比,喂食酒精的小鼠肝脏中的 PRMT1 活性受到抑制。使用肝细胞特异性 PRMT1 敲除小鼠,我们发现 PRMT1 缺失导致肝细胞增殖增强,肝脏大小增加 33%。这种增加的肝细胞增殖与肝细胞核因子 4α(Hnf4α)表达减少有关,Hnf4α 是肝癌的重要调节因子。我们发现,PRMT1 通过精氨酸在(Hnf4α)启动子上的甲基化直接调节 Hnf4α 的表达。在缺乏 PRMT1 的情况下,JMJD6 可以去甲基化 Hnf4α 启动子并抑制其表达。我们能够通过在 PRMT1 敲除小鼠中敲低 JMJD6 来恢复 Hnf4α 的表达并消除肝细胞增殖的增加。在酒精喂养的小鼠中敲低 JMJD6 也能增加 Hnf4α 的表达。然后,我们检查了精氨酸甲基化的缺失是否可能在酒精相关的肝癌中起作用。我们检查了 25 个人 HCC 标本,发现这些标本中精氨酸甲基化水平与 Hnf4α 表达之间存在很强的相关性(R = 0.8;P < 0.01),这表明上述机制在患者中是相关的。
综上所述,这些数据表明,PRMT1 抑制(如酒精诱导)可能导致表观遗传变化,导致 Hnf4α 丢失。这种影响可能有助于酒精促进肝脏肿瘤的能力。(《肝脏病学》2018;67:1109-1126)。